Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

Update Il y a 4 ans
Reference: NCT00808223

Woman and Man

Extract

To establish the safety of alefacept when administered to adolescent subjects with moderate to severe psoriasis.


Inclusion criteria

  • Psoriasis

Links